01863nam 2200349 450 991073434780332120230816094643.0(CKB)5470000002907831(NjHacI)995470000002907831(EXLCZ)99547000000290783120230816d2023 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierApplication of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions Where Are We Now? /edited by Hann-Chorng Kuo[Place of publication not identified] :MDPI - Multidisciplinary Digital Publishing Institute,2023.1 online resource (172 pages)3-0365-7939-7 Evidence has shown that botulinum toxin A has advantages in lower urinary tract dysfunctions (LUTDs), especially in interstitial cystitis, urethral sphincter dysfunction, and inflammatory bladder disorders which currently cannot be adequately treated with oral pharmacological medications. This Special Issue has collected original or review articles that focus on the novel applications of botulinum toxin A in LUTDs. The research has been updated and contains novel therapeutic applications of botulinum toxin for bladder or urethral dysfunctions. This Special Issue of Toxins provides current knowledge surrounding the status of botulinum toxin in functional urology and LUTDs.Application of Botulinum Neurotoxin in Lower Urinary Tract DysfunctionsBotulinum toxinBotulinum toxin.615.329364Kuo Hann-ChorngNjHacINjHaclBOOK9910734347803321Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions3421500UNINA